Griffith DE, Thomson R, Addrizzo-Harris DJ, et al. Sustainability and durability of culture conversion in patients receiving amikacin liposome inhalation suspension (ALIS) for treatment-refractory mycobacterium avium complex lung disease (MAC-LD) in the CONVERT Study. Am J Resp Crit Care Med. 2019;199:A7358.
Bestraling doorbreekt immuuntherapieresistentie bij niet-kleincellige longkanker
aug 2025 | Immuuntherapie, Longoncologie, Radiotherapie